[HTML][HTML] Using big sequencing data to identify chronic SARS-Coronavirus-2 infections

S Harari, D Miller, S Fleishon, D Burstein… - Nature …, 2024 - nature.com
The evolution of SARS-Coronavirus-2 (SARS-CoV-2) has been characterized by the
periodic emergence of highly divergent variants. One leading hypothesis suggests these …

[HTML][HTML] Evolution of the SARS-CoV-2 Omicron Variants: Genetic Impact on Viral Fitness

W Liu, Z Huang, J Xiao, Y Wu, N Xia, Q Yuan - Viruses, 2024 - mdpi.com
Over the last three years, the pandemic of COVID-19 has had a significant impact on
people's lives and the global economy. The incessant emergence of variant strains has …

[HTML][HTML] Sotrovimab: A Review of Its Efficacy against SARS-CoV-2 Variants

D Focosi, A Casadevall, M Franchini, F Maggi - Viruses, 2024 - mdpi.com
Among the anti-Spike monoclonal antibodies (mAbs), the S-309 derivative sotrovimab was
the most successful in having the longest temporal window of clinical use, showing a high …

[HTML][HTML] Evolving spike-protein N-glycosylation in SARS-CoV-2 variants

S Baboo, JK Diedrich, JL Torres, J Copps, B Singh… - Biorxiv, 2023 - ncbi.nlm.nih.gov
Abstract Since> 3 years, SARS-CoV-2 has plunged humans into a colossal pandemic.
Henceforth, multiple waves of infection have swept through the human population, led by …

[HTML][HTML] A bispecific antibody exhibits broad neutralization against SARS-CoV-2 Omicron variants XBB. 1.16, BQ. 1.1 and sarbecoviruses

Y Wang, A Hao, P Ji, Y Ma, Z Zhang, J Chen… - Nature …, 2024 - nature.com
Abstract The Omicron subvariants BQ. 1.1, XBB. 1.5, and XBB. 1.16 of SARS-CoV-2 are
known for their adeptness at evading immune responses. Here, we isolate a neutralizing …

[HTML][HTML] A Candidate DNA Vaccine Encoding the Native SARS-CoV-2 Spike Protein Induces Anti-Subdomain 1 Antibodies

A Frische, V Gunalan, KA Krogfelt, A Fomsgaard… - Vaccines, 2023 - mdpi.com
The ideal vaccine against viral infections should elicit antibody responses that protect
against divergent strains. Designing broadly protective vaccines against SARS-CoV-2 and …

ACE2 mimetic antibody potently neutralizes all SARS-CoV-2 variants and fully protects in XBB. 1.5 challenged monkeys

C Fenwick, P Turelli, Y Duhoo, K Lau, C Herate… - bioRxiv, 2023 - biorxiv.org
The rapid evolution of SARS-CoV-2 to variants with improved transmission efficiency and
reduced sensitivity to vaccine-induced humoral immunity has abolished the protective effect …

[HTML][HTML] Antigen-Heterologous Vaccination Regimen Triggers Alternate Antibody Targeting in SARS-CoV-2-DNA-Vaccinated Mice

A Frische, KA Krogfelt, A Fomsgaard, R Lassaunière - Vaccines, 2024 - mdpi.com
An in-depth analysis of antibody epitopes following vaccination with different regimens
provides important insight for developing future vaccine strategies. B-cell epitopes …

[HTML][HTML] Combining iCn3D and NextStrain to create a novel undergraduate research experience around SARS-CoV-2 variants and commercial antibodies

SG Porter, TM Smith - Frontiers in Genetics, 2023 - frontiersin.org
Undergraduate research experiences are increasingly important in biology education with
efforts underway to provide more projects by embedded them in a course. The shift to online …

[引用][C] Evolving spike-protein N-glycosylation in SARS-CoV-2 variants

B Singh, P Garrett, S Baboo, J Diedrich, J Torres… - 2023